And technically, that is correct
Model: Female C57BL/6J mice aged 18 months Dosage: 3 micrograms of semaglutide injected every other day for two months
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (PIONEER 6)
When used consistently, they result in: Decreased calorie intake Slower gastric emptying Improved insulin sensitivity Substantial weight loss For those with obesity or metabolic dysfunction, this is a medical breakthrough
Some plaintiffs firms still review and file individual cases in state and federal courts for patients who developed pancreatic cancer, acute pancreatitis, or other serious health issues following Victoza use, but these are generally pursued outside of a large centralized pancreatic cancer MDL at this time
This work was supported by: Fundao de Amparo Pesquisa e Inovao do Estado de Santa Catarina (FAPESC)